AJP - Endo Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (May 26, 2009). doi:10.1152/ajpendo.00043.2009
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/2/E358    most recent
00043.2009v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winnick, J. J.
Right arrow Articles by Farmer, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winnick, J. J.
Right arrow Articles by Farmer, B.
Submitted on January 21, 2009
Revised on May 18, 2009
Accepted on May 18, 2009

A physiological increase in the hepatic glycogen level does not affect the response of net hepatic glucose uptake to insulin

Jason J. Winnick1*, Zhibo An2, Mary Courtney Moore2, Christopher J. Ramnanan1, and Ben Farmer1

1 Vanderbilt University
2 Vanderbilt University School of Medicine

* To whom correspondence should be addressed. E-mail: jason.winnick{at}vanderbilt.edu.

To determine the effect of an acute increase in hepatic glycogen on net hepatic glucose uptake (NHGU) and disposition in response to insulin in vivo, studies were performed on two groups of dogs fasted 18h. During the first 4h of the study, somatostatin was infused peripherally, while insulin and glucagon were replaced intraportally in basal amounts. Hyperglycemia was brought about by glucose infusion and either saline (n=7) or fructose (n=7; to stimulate NHGU and glycogen deposition) was infused intraportally. A 2h control period then followed, during which the portal fructose and saline infusions were stopped, allowing NHGU and glycogen deposition in the fructose infused animals to return to rates similar to those that received the saline infusion. This was followed by a 2h experimental period, during which hyperglycemia was continued but the insulin infusion was increased 4-fold in both groups. During the initial 4h glycogen loading period, NHGU averaged 1.18 ± 0.27 and 5.55 ± 0.53 mg/kg/min and glycogen synthesis averaged 0.72 ± 0.24 and 3.98 ± 0.57 mg/kg/min in the saline and fructose groups, respectively (p < 0.05). During the 2h hyperinsulinemic period, NHGU rose from 1.5 ± 0.4 and 0.9 ± 0.2 to 3.1 ± 0.6 and 2.5 ± 0.5 mg/kg/min in the saline and fructose groups, respectively, a change of 1.6 mg/kg/min in both groups despite a significantly greater liver glycogen level in the fructose infused group. Likewise, the metabolic fate of the extracted glucose (glycogen, lactate or carbon dioxide) was not different between groups. These data indicate that an acute physiological increase in the hepatic glycogen content does not alter liver glucose uptake and storage under hyperglycemic/ hyperinsulinemic conditions in the dog.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.